Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Clinical trial NCT00640523 · COMPLETED

Trial details

NCT number: NCT00640523
Sponsor: BioCryst Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)

Start date: 2008-03-01
Primary completion: 2010-11-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.